Recent events
Recent events tied to this brand in public sources.
Back to profile3 entries
2021
Entheon completes acquisition of Lobo Genetics
Entheon completed its acquisition of Lobo Genetics, which became a wholly owned subsidiary of Entheon following an amalgamation.
2021
Entheon completes acquisition of HaluGen
Entheon Biomedical completed its acquisition of all issued and outstanding common shares of HaluGen Life Sciences, making HaluGen a wholly owned subsidiary.
2020
Entheon Biomedical closes private placement
Entheon Biomedical closed a non-brokered private placement for gross proceeds of CAD $3,174,374.25 and allotted and issued 4,232,499 units.